Cilastatin sodium is a pharmaceutical raw material used as a renal dehydropeptidase inhibitor. It is commonly combined with imipenem in antibiotic preparations to prevent the renal metabolism of imipenem, thereby enhancing its antibacterial activity.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 81129-83-1
Pravastatin sodium
pharmaceutical raw material
Esmolol hydrochloride
pharmaceutical raw material
[8-Chloro-6-(2-fluorophenyl)-4H-imidazo[1,5-a][1,4]benzodiazepin-1-yl]methyl hexopyranosiduronic acid
pharmaceutical raw material
Procaterol hydrochloride hemihydrate
pharmaceutical raw material
sodium (Z)-7-[(2R)-2-amino-2-carboxyethyl]sulfanyl-2-[[(1S)-2,2-dimethylcyclopropanecarbonyl]amino]hept-2-enoate
QXPBTTUOVWMPJN-QBNHLFMHSA-M
CC1(C[C@@H]1C(=O)N/C(=C\CCCCSC[C@@H](C(=O)O)N)/C(=O)[O-])C.[Na+]